@shivadas29 @priti899 @NephJC @nephvishnoi @brammahin @hswapnil @arvindcanchi @brian_rifkin @kidney_boy @edgarvlermamd @Nephro_Sparks @divyaa24 @jmteakell @ISNeducation @NDTsocial 1/2 I could find only 4 (older) 1. Nistor I, et al, 2014 @IonuNistor1 @acco
@S_brimble @NICEcomms @wilkiemart It does seem more popular in Europe (and UK) cc @ClaraDay13 for comments? #ScottDisagrees correctly: The previous RCTs had some interesting results and weaknesses (Cochrane SR here https://t.co/5fIwbLMyBq g
RT @crz_garrit: Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease. - PubMed - NCBI https://t.co/7iQ7tUXxts
RT @crz_garrit: Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease. - PubMed - NCBI https://t.co/7iQ7tUXxts
Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease. - PubMed - NCBI https://t.co/7iQ7tUXxts
New @CochraneKidney review: no evidence that convective #dialysis improves survival, but it may reduce cardiac death http://t.co/GXYsV8chbx
No evidence that convective dialysis improves survival, but may reduce cardiac death #Cochrane http://t.co/oVfGf38l9S
No evidence that convective dialysis improves survival, but may reduce cardiac death #Cochrane http://t.co/oVfGf38l9S
No evidence that convective dialysis improves survival, but may reduce cardiac death #Cochrane http://t.co/oVfGf38l9S
Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease - The Cochrane Library http://t.co/Q0pU24WK7l
HDF/HF may reduce CV but not all-cause death in ESKD. Read our Cochrane review. http://t.co/SOGKgJmEu2 GS @DiaverumGlobal @Sydney_Clin_Epi
HDF/HF may reduce CV but not all-cause death in ESKD. Read our Cochrane review. http://t.co/SOGKgJmEu2 GS @DiaverumGlobal @Sydney_Clin_Epi